This issue brings together seven stories from the front lines of clinical medicine, spanning continents and specialties yet united by a common thread: the persistent gap between what medicine can achieve and what patients, especially in resource-constrained settings, actually receive. From a modest renal biopsy study in Barisal to a case study about multi organ disfunction, these pieces remind us that progress in medicine is rarely a single breakthrough moment. More often, it is the sum of careful observation, honest reporting of limitations, and the willingness of clinicians to act decisively when resources and time are both in short supply. We hope this collection offers not just clinical insight, but a sense of the shared challenges facing healthcare systems worldwide.
In Bangladesh, Chronic Kidney Disease is a growing health burden, with diabetes being a major underlying cause and many patients presenting at an advanced stage requiring dialysis. Public perception remains so focused on kidney failure that other kidney diseases are often overlooked. Despite constraints in local research funding, institutions in Bangladesh continue to conduct small-scale studies of different diseases. One such study, done at Sher-E-Bangla Medical College Hospital, Barisal, examined 67 people with glomerulonephritis who underwent renal biopsies revealing different forms of the disease, despite having normal eGFR and creatinine. The study’s focus on identifying potentially treatable disease early offers a valuable model for guiding appropriate management and preventing progression to advanced CKD and dialysis.
Women globally continue to face high risk of mortality and morbidity from breast cancer, with radiotherapy playing a vital role among multiple modules of management. Three-Dimensional Conformal Radiotherapy (3DCRT) has long formed the backbone of breast radiation treatment, but carries the risk of exposing other organs, particularly the heart and lungs, to radiation. Intensity-Modulated Radiation Therapy (IMRT) has shown it can deliver breast cancer radiotherapy with comparable tumor coverage while achieving better dose conformity and substantially less radiation to healthy organs, suggesting a safer treatment approach. It is evident that with more time, better treatments are always on the horizon.
Vitamin D deficiency is widely acknowledged to be linked to or associated with depression. A study at Sylhet MAG Osmani Medical College Hospital examined the vitamin D status of 50 patients across different age groups diagnosed with major depressive disorder (MDD). Vitamin D levels varied significantly by age, with people aged 30 or younger showing substantially lower mean serum vitamin D levels than those over 30. The findings suggest younger patients with MDD may be particularly vulnerable to low vitamin D status. While the cross-sectional design and small convenience sample prevent conclusions about causality, the study supports further investigation of vitamin D as a potentially relevant factor in depression management in Bangladesh.
We are entering a dark phase in medical management with the alarming rise in antibiotic resistance among critical care patients, driven largely by antibiotic misuse. A study highlights the growing threat of multidrug-resistant Klebsiella pneumoniae among critically ill, mechanically ventilated patients in Bangladesh. Among 50 ICU isolates, resistance to commonly used antibiotics was strikingly high, including 76% resistance to meropenem and 74% to imipenem, leaving few effective treatment options. Molecular analysis revealed a particularly concerning burden of resistance genes: OXA-48 in 96% of isolates, KPC in 86%, NDM in 74%, alongside multiple non-β-lactam resistance genes. Colistin remained highly active, with only 2% resistance, though ceftazidime-avibactam resistance reached 52%. The observed 44% mortality underscores the clinical stakes. Despite its single-center design and limited sample size, the study makes a compelling case for stronger antimicrobial stewardship, infection control, molecular surveillance, and coordinated national strategies to contain resistance.
The Optima Pain Consensus addresses a major but often overlooked challenge in Bangladesh: inadequate postoperative pain management. An expert panel of 17 specialists highlights widespread reliance on reactive “SOS” dosing, subjective pain assessment, and prolonged use of intravenous analgesics practices that may delay recovery and contribute to complications, dissatisfaction, and readmissions. The consensus advocates a shift toward proactive, scheduled “By the Clock” multimodal analgesia, supported by objective pain assessment and procedure-specific treatment plans. It also emphasizes individualized risk assessment, avoidance of unsafe NSAID combinations, and earlier transition from parenteral to oral or suppository therapy. Standardized discharge instructions and patient education are recommended to reduce preventable pain-related readmissions, offering a practical, Bangladesh-specific framework for safer, more consistent postoperative care.
Heterotopic pregnancy is a very rare occurrence, and one such case was managed in a resource-limited private practice in Bangladesh. Clinical presentations across two separate episodes, fourteen days apart, confirm just how challenging diagnosis can be. The case illustrates how a coexisting intrauterine pregnancy can mask ectopic components, delaying diagnosis and risking catastrophic complications. It underscores the need for heightened clinical suspicion in patients with prior ectopic history, even in the absence of IVF, and highlights the importance of preparedness for surgical emergencies where diagnostic resources are constrained.
Not all patients respond to medications in the same way, and rare but severe adverse reactions can lead to life-threatening systemic complications. A case report describes a 34-year-old man who developed severe multiorgan dysfunction and septic shock following a two-week course of oral voriconazole for tinea corporis. His complications included acute kidney injury, hepatotoxicity, and left ventricular dysfunction, with an ejection fraction of 30%. He was treated with CytoSorb hemoadsorption integrated with continuous renal replacement therapy, along with sustained low-efficiency dialysis (SLED) and multiple blood product transfusions. The potential role of CytoSorb as an adjunctive therapy for removing circulating cytokines and toxins in severe drug-induced systemic inflammation is gaining traction in recent times.
Taken together, these seven articles paint a picture of medicine as a discipline defined as much by vigilance as by innovation. Whether it is a clinician in Barisal biopsying kidneys before failure sets in, an ICU team racing to counter a toxic drug reaction, or a multi organ disfunction treatment, the common denominator is a refusal to accept “good enough” as the ceiling of care. Many of these studies acknowledge their own limitations small samples, single centers, cross-sectional designs yet each contributes a meaningful piece to a larger, ongoing effort to close the gap between disease and effective treatment. As always, we thank our contributing authors for sharing their clinical experience and research, and we invite our readers to carry these lessons into their own practice.